Nur S. Zainal
Head And Neck Cancer Research Team, No. 1, Jalan SS12/1A
Subang Jaya, 47500, Malaysia
Subang Jaya, 47500, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.
Journal: Frontiers in immunology
Published: August 23, 2021
Case Report: Severe Hyponatremia in Infants With Urinary Tract Infection.
Journal: Frontiers in pediatrics
Published: January 18, 2021
Monitoring T Cells Responses Mounted by Therapeutic Cancer Vaccines.
Journal: Frontiers in molecular biosciences
Published: October 30, 2020
Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance.
Journal: Cancer biology & medicine
Published: September 14, 2019
Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models.
Journal: Targeted oncology
Published: February 27, 2019
IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 27, 2019
The 4717C > G polymorphism in periplakin modulates sensitivity to EGFR inhibitors.
Journal: Scientific reports
Published: July 25, 2018
Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 15, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026